BioDrone Therapeutics Inc.
  • Home
  • About Us
  • Our Sciences
    • Cell-Derived Vesicle
    • BioDrone™ Platform
    • Manufacturing
    • Intellectual Properties
  • Pipeline
  • Publications
    • Publications
    • Posters & Presentations
  • Business
    • Business Model
    • Open Innovation
  • News
    • Press Releases
  • More
    • Home
    • About Us
    • Our Sciences
      • Cell-Derived Vesicle
      • BioDrone™ Platform
      • Manufacturing
      • Intellectual Properties
    • Pipeline
    • Publications
      • Publications
      • Posters & Presentations
    • Business
      • Business Model
      • Open Innovation
    • News
      • Press Releases
BioDrone Therapeutics Inc.
  • Home
  • About Us
  • Our Sciences
    • Cell-Derived Vesicle
    • BioDrone™ Platform
    • Manufacturing
    • Intellectual Properties
  • Pipeline
  • Publications
    • Publications
    • Posters & Presentations
  • Business
    • Business Model
    • Open Innovation
  • News
    • Press Releases

Production Process

CDVs are produced from various human cells by a systematic extrusion and purification process. Currently, CDVs produced from a streamlined manufacturing process are being used to support diverse discovery and preclinical studies by both domestic and global partners. 


CDVs produced via Extrusion technology:


  • Can be applied to a variety of cells without limitations (biocompatible)
  • Efficient way to produce a large quantity of nanovesicles
  • Easily scalable (large-scale extrusion method developed)


2015: Small (1 ml)  →  2019: Intermediate (<1 L)  →  2022: Large (~50 L)

Copyright © 2022 BioDrone Therapeutics Inc. - All Rights Reserved.

  • Contact